MICROPORT: Endovastec's net profit attributable to the parent company for the first three quarters is approximately 429 million yuan, a year-on-year decrease of 22.46%
I'm PortAI, I can summarize articles.
According to the Zhitong Finance APP, MICROPORT announced the performance of Endovastec for the first three quarters of 2025, with operating revenue of approximately 1.015 billion yuan, a year-on-year increase of 4.66%; net profit attributable to shareholders of the listed company was approximately 429 million yuan, a year-on-year decrease of 22.46%; basic earnings per share were 3.54 yuan
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments